Implementing Ultrasound-Guided Microwave Ablation for Benign Thyroid Nodules in ENT Practice: Technical Considerations and Early Clinical Experience

Background/Objectives: Ultrasound-guided microwave ablation (MWA) has emerged as an effective minimally invasive treatment for benign thyroid nodules, but practical guidance regarding implementation of the technique within otorhinolaryngology practice remains limited. This study aimed to describe the implementation of ultrasound-guided MWA for benign thyroid nodules in a tertiary ENT center, with emphasis on technical considerations, procedural safety, and early clinical outcomes. Methods: A retrospective analysis of prospectively collected data included consecutive patients seen at the ENT outpatient clinic between March 2024 and July 2025. All procedures were performed by a single ENT surgeon, and technical aspects were described. Procedural characteristics, pain, complications, nodule volume reduction, compressive symptoms, cosmetic outcomes, and thyroid function were evaluated through 3-month follow-up. Results: Twenty-five patients underwent ultrasound-guided MWA for 30 benign thyroid nodules. All procedures were successfully completed under local anesthesia. No major complications occurred; two patients developed minor, self-limiting ecchymosis. Median nodule volume decreased from 12.77 mL (IQR, 4.13–17.74) at baseline to 3.81 mL (IQR, 1.31–7.60) at 3 months, corresponding to a mean volume reduction ratio of 63.8%. Significant improvements in compressive symptoms and cosmetic scores were observed (p < 0.001). All patients remained euthyroid, with no cases of new-onset hypothyroidism. Conclusions: This early experience supports the feasibility and short-term procedural safety of ultrasound-guided MWA for selected benign thyroid nodules within an ENT setting. Careful patient selection, meticulous technique, and structured operator training appear to be key components for successful implementation. Beyond its favorable early clinical outcomes, this study provides a practical framework for centers seeking to establish thyroid MWA programs.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-09-11
DOI
https://doi.org/10.3390/jcm15187053
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementing Ultrasound-Guided Microwave Ablation for Benign Thyroid Nodules in ENT Practice: Technical Considerations and Early Clinical Experience

Maria Zisoglou, Dimitrios P. Askitis, Konstantinos Chaidas, Chrysovalantis Stylianou et al.
Journal of Clinical Medicine
Thyroid Cancer Diagnosis and Treatment
article

Implementing Ultrasound-Guided Microwave Ablation for Benign Thyroid Nodules in ENT Practice: Technical Considerations and Early Clinical Experience

Maria Zisoglou, Dimitrios P. Askitis, Konstantinos Chaidas, Chrysovalantis Stylianou, Hippocrates Moschouris, Michael Katotomichelakis
article en

Abstract

Background/Objectives: Ultrasound-guided microwave ablation (MWA) has emerged as an effective minimally invasive treatment for benign thyroid nodules, but practical guidance regarding implementation of the technique within otorhinolaryngology practice remains limited. This study aimed to describe the implementation of ultrasound-guided MWA for benign thyroid nodules in a tertiary ENT center, with emphasis on technical considerations, procedural safety, and early clinical outcomes. Methods: A retrospective analysis of prospectively collected data included consecutive patients seen at the ENT outpatient clinic between March 2024 and July 2025. All procedures were performed by a single ENT surgeon, and technical aspects were described. Procedural characteristics, pain, complications, nodule volume reduction, compressive symptoms, cosmetic outcomes, and thyroid function were evaluated through 3-month follow-up. Results: Twenty-five patients underwent ultrasound-guided MWA for 30 benign thyroid nodules. All procedures were successfully completed under local anesthesia. No major complications occurred; two patients developed minor, self-limiting ecchymosis. Median nodule volume decreased from 12.77 mL (IQR, 4.13–17.74) at baseline to 3.81 mL (IQR, 1.31–7.60) at 3 months, corresponding to a mean volume reduction ratio of 63.8%. Significant improvements in compressive symptoms and cosmetic scores were observed (p < 0.001). All patients remained euthyroid, with no cases of new-onset hypothyroidism. Conclusions: This early experience supports the feasibility and short-term procedural safety of ultrasound-guided MWA for selected benign thyroid nodules within an ENT setting. Careful patient selection, meticulous technique, and structured operator training appear to be key components for successful implementation. Beyond its favorable early clinical outcomes, this study provides a practical framework for centers seeking to establish thyroid MWA programs.

Journal of Clinical MedicineVol. 15(18)
Democritus University of Thrace (GR), University Hospital of Alexandroupolis (GR)
Openalex Percentile: Top 11%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.